Longevity on Antiretroviral Therapy for Children Living with HIV/AIDS--A Price to Pay for Success?

Indian J Pediatr. 2016 Mar;83(3):197-9. doi: 10.1007/s12098-016-2036-z. Epub 2016 Feb 6.

Authors

Mamatha M Lala¹, Rashid H Merchant²

Affiliations

¹ Pediatric Centre of Excellence for HIV Care, LTMMC & LTMGH; Committed Communities Development Trust (CCDT); Bai Jerbai Wadia Hospital for Children, Nowrosjee Wadia Maternity Hospital, Mumbai, Maharashtra, India.
² Department of Pediatrics, Dr. Balabhai Nanavati Hospital, Mumbai, 400 050, Maharashtra, India. deandoc2000@hotmail.com.

PMID: 26850707
DOI: 10.1007/s12098-016-2036-z

No abstract available

Publication types

Editorial
Comment

MeSH terms

Acquired Immunodeficiency Syndrome / drug therapy*
Anti-HIV Agents / therapeutic use
Antiretroviral Therapy, Highly Active
Child
Communicable Diseases
HIV Infections / drug therapy
Humans
Longevity*

Substances

Anti-HIV Agents